BlackRock Investment Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$26M Buy
180,979
+20,470
+13% +$2.94M 0.03% 514
2016
Q3
$19M Buy
160,509
+7,363
+5% +$869K 0.02% 623
2016
Q2
$16.2M Sell
153,146
-245,494
-62% -$26M 0.02% 662
2016
Q1
$44.4M Sell
398,640
-821,356
-67% -$91.5M 0.06% 312
2015
Q4
$191M Buy
1,219,996
+16,161
+1% +$2.53M 0.24% 94
2015
Q3
$158M Buy
1,203,835
+37,915
+3% +$4.98M 0.21% 100
2015
Q2
$203M Sell
1,165,920
-112,978
-9% -$19.7M 0.25% 91
2015
Q1
$221M Sell
1,278,898
-24,263
-2% -$4.18M 0.29% 79
2014
Q4
$169M Sell
1,303,161
-23,894
-2% -$3.09M 0.22% 104
2014
Q3
$171M Buy
1,327,055
+387,593
+41% +$49.9M 0.24% 90
2014
Q2
$83.1M Sell
939,462
-232,262
-20% -$20.6M 0.11% 183
2014
Q1
$110M Buy
1,171,724
+97,689
+9% +$9.19M 0.16% 134
2013
Q4
$121M Buy
1,074,035
+380,675
+55% +$43M 0.18% 116
2013
Q3
$54.7M Buy
693,360
+205,690
+42% +$16.2M 0.09% 207
2013
Q2
$32.1M Buy
+487,670
New +$32.1M 0.06% 300